Innovating Quality Control and External Quality Assurance for HIV-1 Recent Infection Testing: Empowering HIV Surveillance in Lao PDR
Viruses · 2025
DOI: 10.3390/v17071004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Supaporn Suparak und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Quality Control, Quality Assurance, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreements T…, CDC HHS, President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreements.
Abstract (Originalsprache)
Quality assurance programs are critical to ensuring the consistency and reliability of point-of-care surveillance test results. In 2022, we launched Laos’ inaugural quality control (QC) and external quality assessment (EQA) program for national HIV recent infection surveillance. Our study aims to implement the first QC and EQA program for national HIV recent infection surveillance in Laos, utilizing non-infectious dried tube specimens (DTS) for quality control testing. This initiative seeks to monitor and assure the quality of HIV infection surveillance. We employed the Asante HIV-1 Rapid Test for Recent Infection (HIV-1 RTRI) point-of-care kit, using plasma specimens from the Thai Red Cross Society to create dried tube specimens (DTS). The DTS panels, including HIV-1 negative, HIV-1 recent, and HIV-1 long-term samples, met ISO 13528:2022 standards to ensure homogeneity and stability. These panels were transported from the Thai National Institute of Health (Thai NIH) to the Laos National Center for Laboratory and Epidemiology (NCLE) and subsequently shipped to 12 remote laboratories at ambient temperature. The laboratory results were electronically transmitted to Thai NIH 15 days after receiving the panel for performance analysis. The concordance results with the sample types were scored, and laboratories that achieved 100% concordance across all sample panels were considered to have satisfactorily met the established standards. Almost all laboratories demonstrated satisfactory results with 100% concordance across all sample panels during all three rounds of QC: 11 out of 12 (92%) in June, 10 out of 12 (83%) in July, and 11 out of 12 (91%) in August. The two rounds of EQA performed in June and August 2022 were satisfied by 8 out of 11 (72%) and 5 out of 10 (50%) laboratories, respectively. QC and EQA monitoring identified errors such as testing protocol mistakes and insufficient DTS panel dissolution, leading to improvements in HIV recency testing quality. Laboratories that reported errors were corrected and implemented further preventive actions. The QC and EQA program for HIV-1 RTRI identified errors in HIV recent infection testing. Implementing a specialized QC and EQA program for DTS marks a significant advancement in improving the accuracy and consistency of HIV recent infection surveillance. Continuous assessment is vital for addressing recurring issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.
- Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand.
- National Center for Laboratory and Epidemiology (NCLE), Ministry of Health, Vientiane 01030, Laos.
- U.S. Centers for Disease Control and Prevention, Division of Global HIV/TB, Thailand and Laos, Nonthaburi 11000, Thailand.
ORCID-Profile: Supaporn Suparak, Kanokwan Ngueanchanthong, Siriphailin Jomjunyoung, Wipawee Thanyacharern, Sirilada Pimpa Chisholm, Nitis Smanthong, Pojaporn Pinrod, Theerawit Tasaneeyapan
Förderung
- the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreements T…
- CDC HHS
- President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreements
Zitieren
APA
Suparak, S., Ngueanchanthong, K., Unpol, P., Jomjunyoung, S., Thanyacharern, W., Chisholm, S. P., Smanthong, N., Pinrod, P., Yingyong, T., Xangsayarath, P., Xayadeth, S., Somoulay, V., Tasaneeyapan, T., Nookhai, S., Rojanawiwat, A., & Northbrook, S. (2025). Innovating Quality Control and External Quality Assurance for HIV-1 Recent Infection Testing: Empowering HIV Surveillance in Lao PDR. Viruses. https://doi.org/10.3390/v17071004
Vancouver
Suparak S, Ngueanchanthong K, Unpol P, Jomjunyoung S, Thanyacharern W, Chisholm SP, et al. Innovating Quality Control and External Quality Assurance for HIV-1 Recent Infection Testing: Empowering HIV Surveillance in Lao PDR. Viruses. 2025. doi:10.3390/v17071004
BibTeX
@article{Suparak2025,
author = {Suparak, Supaporn and Ngueanchanthong, Kanokwan and Unpol, Petai and Jomjunyoung, Siriphailin and Thanyacharern, Wipawee and Chisholm, Sirilada Pimpa and Smanthong, Nitis and Pinrod, Pojaporn and Yingyong, Thitipong and Xangsayarath, Phonepadith and Xayadeth, Sinakhone and Somoulay, Virasack and Tasaneeyapan, Theerawit and Nookhai, Somboon and Rojanawiwat, Archawin and Northbrook, Sanny},
title = {Innovating Quality Control and External Quality Assurance for HIV-1 Recent Infection Testing: Empowering HIV Surveillance in Lao PDR},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17071004}
}
EUVIMED